Palvella Therapeutics (PVLA) – Analysts’ Weekly Ratings Changes
A number of firms have modified their ratings and price targets on shares of Palvella Therapeutics (NASDAQ: PVLA) recently: 4/9/2025 – Palvella Therapeutics is now covered by analysts at Chardan Capital. They set a “buy” rating and a $50.00 price target on the stock. 4/1/2025 – Palvella Therapeutics had its “buy” rating reaffirmed by analysts […]
A number of firms have modified their ratings and price targets on shares of Palvella Therapeutics (NASDAQ: PVLA) recently: 4/9/2025 – Palvella Therapeutics is now covered by analysts at Chardan Capital. They set a “buy” rating and a $50.00 price target on the stock. 4/1/2025 – Palvella Therapeutics had its “buy” rating reaffirmed by analysts […]
